利用大自然的武器库:急性髓性白血病中基于大的治疗方法的下一步
1Clinical Medicine Grade 2022, School of Clinical Medicine, Hangzhou Normal University, No. 2318, Yuhangtang Road, Cangqian Subdistrict, Yuhang Zone, Hangzhou, 311121, Zhejiang Province, People's Republic of China. xc694931675@outlook.com.
Medical oncology (Northwood, London, England)
|December 26, 2025
概括
(大) 提取物在诱导急性髓性白血病 (AML) 细胞死亡方面表现有前途. 需要进一步的研究来标准化提取物,并探索其在体内治疗潜力.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
背景情况:
- 急性髓性白血病 (AML) 仍然是一个具有挑战性的血液恶性瘤.
- 在初步研究中,Allium sativum (大) 提取物已经证明了亲亡的效果.
- 了解天然化合物在AML中的治疗潜力是一个活跃的研究领域.
研究的目的:
- 赞扬和建立在白提取物在AML中的亲亡效应的ex vivo发现的基础上.
- 提出提高大提取物作为AML治疗的翻译潜力的关键考虑因素.
- 建议未来研究和验证的途径.
主要方法:
- 对现有ex vivo研究结果的审查和评论.
- 强调植物化学标准化Allium sativum提取物.
- 扩大机理学研究 (外部亡,ROS) 的建议.
- 针对耐性白血病干细胞的建议 (长期暴露,组合疗法).
- 倡导使用患者衍生的异种移植模型进行体内验证.
主要成果:
- 这项研究承认,大提取物对初级AML细胞的ex vivo预亡效应具有意义.
- 突出了提高可重现性和机制理解的关键考虑因素.
- 提出了增强抗抗性白血病干细胞疗效的策略.
- 强调需要进行体内验证.
结论:
- 对大提取物的标准化植物化学表征对于可再生性至关重要.
- 需要对亡途径和ROS进行进一步的机械研究.
- 组合疗法和体内模型对于评估AML的临床潜力至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K


